Which of the following is a class of drugs specifically mentioned under MAC policy?

The correct answer is Intranasal Corticosteroids (INCS), as they are specifically delineated within the MAC (maximum allowable cost) policy, which governs pricing structures for certain categories of medications under Saskatchewan's healthcare system. MAC policies are designed to ensure that patients receive necessary medications at controlled costs, allowing for price consistency and accessibility.

Intranasal Corticosteroids are often used in the management of allergic rhinitis and other nasal inflammatory conditions, making their inclusion in policies relevant for ensuring that patients have access to affordable treatment options. The regulation of these drugs under MAC policy reflects a focus on managing public health effectively, balancing medication availability while controlling costs.

Other drug categories, such as beta-blockers, statins, and antihistamines, while widely used in clinical practice, may not be subjected to the same MAC policy specifications aimed explicitly at Intranasal Corticosteroids. Each medication class has different mechanisms and therapeutic uses, but in this context, the emphasis is on ensuring the affordability of a particular class that is frequently prescribed for common conditions.